<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> stem cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>) are considered to be the origin of <z:e sem="disease" ids="C0699753" disease_type="Neoplastic Process" abbrv="">cancer relapse</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The better understanding of <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>, including <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), may facilitate prevention and treatment </plain></SENT>
<SENT sid="2" pm="."><plain>This study aimed to establish a <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> enrichment model via the induction of epithelial-mesenchymal transition (EMT) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>We established an EMT model using the SW480 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell line by CDH1 knockdown using shRNA interference </plain></SENT>
<SENT sid="4" pm="."><plain>CD24+CD44+ cells were enriched in the CDH1 knockdown cells </plain></SENT>
<SENT sid="5" pm="."><plain>The cells exhibited mesenchymal <z:mp ids='MP_0000002'>morphology</z:mp> and expressed high levels of EMT-related proteins, which confirmed that these cells had undergone EMT </plain></SENT>
<SENT sid="6" pm="."><plain>Our results further showed that the proliferation rate of the transfected cells was reduced, whereas their colony-forming capacity and <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in vivo was significantly enhanced compared to the control cells </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, these cells were highly enriched <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> (compared to <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>) and may be used as a stable model for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> research and anticancer drug screening </plain></SENT>
</text></document>